The combination of low doses of UA with DXR strongly reduced DXR-induced AKT phosphorylation, and further decreased p21 levels, especially in synovial sarcoma cells, thereby enhancing DXR-mediated antiproliferative effects (Fig 6). This evidence concerns the gene CDKN1A and synovial sarcoma.